Skip to main content
Year archive

Hutchmed (China) Limited — 2020 filings

All 122 regulatory filings released by Hutchmed (China) Limited (HCM) in 2020, sourced directly from the official regulator.

122 Filings
2020 Period
2020 filings (122)
Filing Released Lang
6-K
Regulatory Filings
2020-12-31 English
Total Voting Rights
Regulatory Filings
2020-12-31 English
Blocklisting Six Monthly Return
Regulatory Filings
2020-12-31 English
NMPA approval of Surufatinib in China for ep-NET
Regulatory Filings
2020-12-30 English
6-K
Regulatory Filings
2020-12-29 English
US NDA Rolling Submission of Surufatinib Initiated
Regulatory Filings
2020-12-29 English
6-K
Regulatory Filings
2020-12-22 English
Chi-Med to Present at JPM
Regulatory Filings
2020-12-22 English
6-K
Regulatory Filings
2020-12-15 English
Grant of Share Options under Share Option Scheme
Director's Dealing
2020-12-15 English
6-K
Regulatory Filings
2020-11-30 English
Total Voting Rights
Regulatory Filings
2020-11-30 English
6-K
Regulatory Filings
2020-11-27 English
SC 13D/A
Major Shareholding Notification
2020-11-27 English
Notification of Dilution of Voting Rights
Major Shareholding Notification
2020-11-27 English
6-K
Regulatory Filings
2020-11-17 English
US$100m Equity Investment by CPP Investments
Capital/Financing Update
2020-11-17 English
6-K
Regulatory Filings
2020-11-05 English
Chi-Med to Present HMPL-689 Clinical Data at ASH
Regulatory Filings
2020-11-05 English
6-K
Regulatory Filings
2020-10-30 English
Chi-Med to Attend Upcoming Conferences
Regulatory Filings
2020-10-30 English
6-K
Regulatory Filings
2020-10-30 English
Total Voting Rights
Regulatory Filings
2020-10-30 English
6-K
Regulatory Filings
2020-09-30 English
Total Voting Rights
Regulatory Filings
2020-09-30 English
6-K
Regulatory Filings
2020-09-21 English
Surufatinib Data at ESMO and in Lancet Oncology
Regulatory Filings
2020-09-21 English
6-K
Regulatory Filings
2020-09-17 English
Second Chinese NDA Acceptance for Surufatinib
Regulatory Filings
2020-09-17 English
6-K
Regulatory Filings
2020-09-04 English
Chi-Med Initiates Global Phase III Trial
Regulatory Filings
2020-09-04 English
6-K
Regulatory Filings
2020-09-03 English
Chi-Med Initiates a Phase II Trial
Regulatory Filings
2020-09-03 English
6-K
Regulatory Filings
2020-08-28 English
Total Voting Rights
Regulatory Filings
2020-08-28 English
6-K
Regulatory Filings
2020-08-24 English
Clinical Data to be Presented at ESMO 2020
Regulatory Filings
2020-08-24 English
6-K
Regulatory Filings
2020-08-12 English
Grant of Share Options under Share Option Scheme
Share Issue/Capital Change
2020-08-12 English
6-K
Regulatory Filings
2020-08-10 English
Surufatinib Marketing Authorization Application
Regulatory Filings
2020-08-10 English
6-K
Regulatory Filings
2020-07-30 English
Interim Results and Clinical Update
Earnings Release H1 2020
2020-07-30 English
6-K
Regulatory Filings
2020-07-30 English
S-8
Regulatory Filings
2020-07-30 English
Block Admission Application
Share Issue/Capital Change
2020-07-30 English
6-K
Regulatory Filings
2020-07-28 English
Chi-Med & Lilly Collaborate on Elunate in China
Regulatory Filings
2020-07-28 English
Savolitinib NDA Granted Priority Review in China
Regulatory Filings
2020-07-28 English
6-K
Regulatory Filings
2020-07-24 English
Chi-Med Initiates HMPL-306 Phase I Trial in China
Regulatory Filings
2020-07-24 English
6-K
Regulatory Filings
2020-07-08 English
Holding(s) in Company
Major Shareholding Notification
2020-07-08 English
6-K
Regulatory Filings
2020-07-07 English
SC 13D/A
Major Shareholding Notification
2020-07-07 English
Holding(s) in Company
Major Shareholding Notification
2020-07-07 English
Notification of Dilution of Voting Rights
Regulatory Filings
2020-07-07 English
SCHEDULE 13D
Major Shareholding Notification
2020-07-06 English
6-K
Regulatory Filings
2020-06-29 English
Blocklisting Six Monthly Return
Regulatory Filings
2020-06-29 English
6-K
Regulatory Filings
2020-06-26 English
Notice of Results
Report Publication Announcement
2020-06-26 English
6-K
Regulatory Filings
2020-06-25 English
$100 Million Equity Investment by General Atlantic
Capital/Financing Update
2020-06-25 English
6-K
Regulatory Filings
2020-06-18 English
Fruquintinib Granted US FDA Fast Track Designation
Regulatory Filings
2020-06-18 English
6-K
Regulatory Filings
2020-06-09 English
US$95m Guangzhou Land Compensation Agreement
Regulatory Filings
2020-06-09 English
6-K
Regulatory Filings
2020-06-04 English
Continuation of Phase III FRUTIGA Study
Regulatory Filings
2020-06-04 English
Second Price Monitoring Extn
Regulatory Filings
2020-06-02 English
Price Monitoring Extension
Regulatory Filings
2020-06-02 English
6-K
Regulatory Filings
2020-06-01 English
Chi-Med Plans to Submit US NDA for Surufatinib
Regulatory Filings
2020-06-01 English
6-K
Regulatory Filings
2020-05-29 English
Chi-Med to Discuss Data Presented at ASCO20
Regulatory Filings
2020-05-29 English
NDA Acceptance in China for Savolitinib
Regulatory Filings
2020-05-29 English
6-K
Regulatory Filings
2020-05-26 English
Chi-Med and BeiGene Enter Clinical Collaboration
Regulatory Filings
2020-05-26 English
6-K
Regulatory Filings
2020-05-14 English
Clinical Data to be Presented at ASCO20
Regulatory Filings
2020-05-14 English
Second Price Monitoring Extn
Regulatory Filings
2020-05-11 English
Price Monitoring Extension
Regulatory Filings
2020-05-11 English
6-K
Regulatory Filings
2020-05-11 English
Chi-Med to Attend Upcoming Investor Conferences
Regulatory Filings
2020-05-11 English
20-F/A
Annual Report FY 2019
2020-04-29 English
6-K
Regulatory Filings
2020-04-29 English
Grant of Share Options under Share Option Scheme
Director's Dealing
2020-04-29 English
6-K
Regulatory Filings
2020-04-27 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2020-04-27 English
6-K
Regulatory Filings
2020-04-22 English
Virtual Presentations of Surufatinib at AACR
Regulatory Filings
2020-04-22 English
6-K
Regulatory Filings
2020-04-21 English
Grant of LTIP Awards and Share Options
Regulatory Filings
2020-04-21 English
6-K
Regulatory Filings
2020-04-17 English
Surufatinib Granted FDA Fast Track Designations
Regulatory Filings
2020-04-17 English
F-3ASR
Regulatory Filings
2020-04-06 English
6-K
Regulatory Filings
2020-03-31 English
6-K
Regulatory Filings
2020-03-25 English
Regulatory Filings 2020
Regulatory Filings
2020-03-19 English
6-K
Regulatory Filings
2020-03-09 English
Regulatory Filings 2020
Regulatory Filings
2020-03-06 English
6-K
Regulatory Filings
2020-03-03 English
20-F
Annual Report FY 2019
2020-03-03 English
6-K
Regulatory Filings
2020-02-25 English
Regulatory Filings 2020
Regulatory Filings
2020-02-21 English
SC 13G
Major Shareholding Notification
2020-02-14 English
Regulatory Filings 2020
Regulatory Filings
2020-02-12 English
6-K
Regulatory Filings
2020-02-10 English
6-K
Regulatory Filings
2020-02-06 English
6-K
Regulatory Filings
2020-01-31 English
6-K
Regulatory Filings
2020-01-29 English
SC 13D/A
Major Shareholding Notification
2020-01-29 English
6-K
Regulatory Filings
2020-01-23 English
424B5
Regulatory Filings
2020-01-23 English
6-K
Regulatory Filings
2020-01-22 English
424B5
Regulatory Filings
2020-01-21 English
6-K
Regulatory Filings
2020-01-21 English
6-K
Regulatory Filings
2020-01-21 English
Regulatory Filings 2020
Regulatory Filings
2020-01-15 English
6-K
Regulatory Filings
2020-01-13 English
6-K
Regulatory Filings
2020-01-06 English